11 – 20 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
(
- Contribution to journal › Article
- 2021
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
(
- Contribution to journal › Scientific review
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
(
- Contribution to journal › Article
-
Mark
The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria
(
- Contribution to journal › Article
-
Mark
Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients
(
- Contribution to journal › Article
- 2020
-
Mark
New generation genetic testing entering the clinic
(
- Contribution to journal › Article
-
Mark
Do variants in IRF2BPL cause both neurological disorders and keratoconus 8?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Disappearance of familially aggregated paralysis agitans in subsequent generations: a 135-year follow up study
(
- Contribution to journal › Published meeting abstract
-
Mark
Long term outcome of Parkinson’s disease and validation of a new clinical classification system.
(
- Contribution to journal › Published meeting abstract
-
Mark
Ataxia project in Scania, Sweden: Study outline and current status
(
- Contribution to journal › Published meeting abstract